Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Unaudited Condensed Interim Consolidated Statements of Shareholders' Equity and Deficit

v3.20.2
Unaudited Condensed Interim Consolidated Statements of Shareholders' Equity and Deficit - USD ($)
Share Capital [Member]
Contributed Surplus [Member]
Net Income (Deficit) [Member]
Total
Beginning balance at Dec. 31, 2018 $ 170,502,394 $ 6,652,409 $ (172,937,694) $ 4,217,109
Beginning balance, share at Dec. 31, 2018 21,675,849      
Statement Line Items [Line Items]        
Issued pursuant to agency agreement $ 13,717,131 13,717,131
Issued pursuant to agency agreement, shares 8,455,882      
Share issue expense $ (1,498,498) (1,498,498)
Warrants exercised during the period $ 7,002,043 7,002,043
Warrants exercised during the period, shares 1,018,506      
Stock based compensation 991,408 991,408
Net and comprehensive loss (42,755,746) (42,755,746)
Ending balance at Jun. 30, 2019 $ 189,723,070 7,643,817 (215,693,440) (18,326,553)
Ending balance, shares at Jun. 30, 2019 31,150,237      
Beginning balance at Dec. 31, 2019 $ 194,859,415 8,303,527 (214,844,773) $ (11,681,831)
Beginning balance, share at Dec. 31, 2019 39,907,681     39,907,681
Statement Line Items [Line Items]        
Issued pursuant to agency agreement [1] $ 12,818,657 $ 12,818,657
Issued pursuant to agency agreement, shares [1] 23,923,700      
Share issue expense $ (487,788) (487,788)
Common stock equivalents converted $ 800 800
Common stock equivalents converted, shares 8,000,000      
Warrants exercised during the period $ 2,910,711 2,910,711
Warrants exercised during the period, shares 3,750,000      
Stock based compensation 434,663 434,663
Net and comprehensive loss (1,911,242) (1,911,242)
Ending balance at Jun. 30, 2020 $ 210,101,795 $ 8,738,190 $ (216,756,015) $ 2,083,970
Ending balance, shares at Jun. 30, 2020 75,581,381     75,581,381
[1] Includes net proceeds from the issuance of common share equivalents (see note 8a)